Beacon Roofing Supply Inc. adopted a poison pill strategy on Tuesday, designed to thwart the $11 billion hostile takeover bid launched by tech and software company QXO Inc. the previous day. https://t.co/ZpAdWkkUqX
Beacon adopts poison pill https://t.co/kiVFJ10UX0 https://t.co/2lUxOk6Czd
Beacon Roofing Supply has adopted a poison pill defense as the building products company pushes back against a hostile takeover approach from QXO https://t.co/38tBecGmQr
Beacon Roofing Supply Inc. is facing a hostile takeover bid from QXO Inc., which has proposed an all-cash tender offer valued at approximately $11 billion to acquire the company. Beacon's board previously rejected QXO's initial acquisition proposal as too low. In response to the hostile bid, Beacon has adopted a poison pill strategy, a defensive maneuver aimed at protecting shareholder interests. The poison pill allows existing shareholders to purchase additional shares at a discount, making it more difficult for QXO to gain control. QXO has reaffirmed its offer of $124.25 per share, despite Beacon's defensive measures. The situation has escalated, with Beacon's CEO Julian Francis discussing the ongoing negotiations and communications with QXO in various media appearances.